TY - JOUR
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Analgesics, Opioid/adverse effects/therapeutic use
KW - Area Under Curve
KW - Chronic Disease/drug therapy
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - Opioid-Related Disorders/diagnosis/prevention & control
KW - Pain Measurement
KW - Pain/drug therapy
KW - Psychometrics
KW - Risk Assessment
KW - ROC Curve
KW - Surveys and Questionnaires
KW - United States
KW - Urinalysis
AU - S. F. Butler
AU - S. H. Budman
AU - G. J. Fanciullo
AU - R. N. Jamison
A1 - 
AB - OBJECTIVES: The Current Opioid Misuse Measure (COMM) is a self-report measure of risk for aberrant medication-related behavior among persons with chronic pain who are prescribed opioids for pain. It was developed to complement predictive screeners of opioid misuse potential and improve a clinician's ability to periodically assess a patient's risk for opioid misuse. The aim of this study was to cross-validate the COMM with a sample of chronic noncancer pain patients. METHODS: Two hundred and twenty-six participants prescribed opioids for pain were recruited from 5 pain management centers in the United States. Participants completed the 17-item COMM and a series of self-report measures. Patients were rated by their treating physician, had a urine toxicology screen, and were classified on the Aberrant Drug Behavior index. RESULTS: The reliability and predictive validity in this cross validation as measured by the area under the curve (AUC) were found to be highly significant (AUC=0.79) and not significantly different from the AUC obtained in the original validation study (AUC=0.81). Reliability (coefficient alpha) was 0.83, which is comparable to the 0.86 obtained in the original sample. DISCUSSION: Results of the cross validation suggest that the psychometric parameters of the COMM are not based solely on unique characteristics of the initial validation sample. The COMM seems to be a reliable and valid screening tool to help detect current aberrant drug-related behavior among chronic pain patients.
BT - The Clinical journal of pain
C5 - Opioids & Substance Use; Measures
CP - 9
CY - United States
DO - 10.1097/AJP.0b013e3181f195ba
IS - 9
JF - The Clinical journal of pain
N2 - OBJECTIVES: The Current Opioid Misuse Measure (COMM) is a self-report measure of risk for aberrant medication-related behavior among persons with chronic pain who are prescribed opioids for pain. It was developed to complement predictive screeners of opioid misuse potential and improve a clinician's ability to periodically assess a patient's risk for opioid misuse. The aim of this study was to cross-validate the COMM with a sample of chronic noncancer pain patients. METHODS: Two hundred and twenty-six participants prescribed opioids for pain were recruited from 5 pain management centers in the United States. Participants completed the 17-item COMM and a series of self-report measures. Patients were rated by their treating physician, had a urine toxicology screen, and were classified on the Aberrant Drug Behavior index. RESULTS: The reliability and predictive validity in this cross validation as measured by the area under the curve (AUC) were found to be highly significant (AUC=0.79) and not significantly different from the AUC obtained in the original validation study (AUC=0.81). Reliability (coefficient alpha) was 0.83, which is comparable to the 0.86 obtained in the original sample. DISCUSSION: Results of the cross validation suggest that the psychometric parameters of the COMM are not based solely on unique characteristics of the initial validation sample. The COMM seems to be a reliable and valid screening tool to help detect current aberrant drug-related behavior among chronic pain patients.
PP - United States
PY - 2010
SN - 1536-5409; 0749-8047
SP - 770
EP - 776
EP - 
T1 - Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy
T2 - The Clinical journal of pain
TI - Cross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapy
U1 - Opioids & Substance Use; Measures
U2 - 20842012
U3 - 10.1097/AJP.0b013e3181f195ba
VL - 26
VO - 1536-5409; 0749-8047
Y1 - 2010
ER -